{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Metabolic Enzyme & Protease > IbrolipimCAS：133208-93-2
Molecular Formula：C19H20BrN2O4P
Molecular Weight：451.25
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 133208-93-2 |
| Name | Ibrolipim |
| Molecular Formula | C19H20BrN2O4P |
| Molecular Weight | 451.25 |
| Solubility | Soluble in DMSO |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| MDL | MFCD00897807 |
| SMILES | CCOP(=O)(CC1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)Br)C#N)OCC |
| InChIKey | KPRTURMJVWXURQ-UHFFFAOYSA-N |
| InChI | InChI=1S/C19H20BrN2O4P/c1-3-25-27(24，26-4-2)13-14-5-7-15(8-6-14)19(23)22-18-10-9-17(20)11-16(18)12-21/h5-11H，3-4，13H2，1-2H3，(H，22，23) |
| PubChem CID | 131601 |
| Target Point | LPL |
| Passage | Metabolic Enzyme&Protease |
| Background | Lipoprotein lipase is an activator of lipoprotein lipase (LPL). Ibrolipim can reduce plasma triglycerides and increase the level of high-density lipoprotein cholesterol. |
| Unit | Bottle |
| Specification | 2mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
